AI Article Synopsis

  • Hyperhemolysis syndrome (HHS) is a rare and severe complication after blood transfusions that leads to the destruction of both the recipient's and the donor's red blood cells.
  • The exact causes of HHS are not well understood, making it challenging to manage, especially in pregnant individuals.
  • This report highlights a case of HHS in a pregnant woman with sickle cell disease and emphasizes the importance of recognizing HHS as a potential diagnosis in patients with worsening anemia despite receiving blood transfusions.

Article Abstract

Hyperhemolysis syndrome (HHS) is a rare and severe posttransfusion complication characterized by the destruction of both recipient and donor red blood cells. The underlying mechanism of HHS is not fully understood and proper management can be difficult. Furthermore, there are few reports regarding HHS in pregnancy. We report on the development and management of HHS in a pregnant woman with known compound sickle cell disease (SCD)/β0-thalassemia and alloimmunization after transfusion of packed red blood cells (PRBC). We aim to raise awareness on this diagnostically challenging and life-threatening type of hemolysis with this report, and to stress the need to consider the diagnosis of HHS in SCD patients with progressive anemia despite PRBC administration.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000533776DOI Listing

Publication Analysis

Top Keywords

hyperhemolysis syndrome
8
pregnant woman
8
woman compound
8
compound sickle
8
sickle cell
8
red blood
8
blood cells
8
hhs
5
"don't add
4
add fuel
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!